NASHVILLE, Tenn. / Feb 20, 2025 / Business Wire / HCA Healthcare, Inc. (NYSE: HCA), is scheduled to present virtually at the following healthcare conferences:
March 4, 2025 at 1:50pm ET at TD Cowen’s 45th Annual Healthcare Conference.
March 11, 2025 at 1:30pm ET at Barclays’ 27th Annual Global Healthcare Conference.
March 19, 2025 at 2:15pm ET at KeyBanc’s 5th Annual Healthcare Forum.
March 20, 2025 at 10:00am ET at Oppenheimer’s 35th Annual Healthcare MedTech & Services Conference.
A link to the live audio webcast, where applicable, and copies of any related presentation materials will be made available at the Investor Relations section of the Company’s website, www.hcahealthcare.com.
Dates and times may be subject to change, please check the conference schedule or the Investor Relations section of the Company’s website for the latest information.
About HCA Healthcare
Nashville-based HCA Healthcare is one of the nation’s leading providers of healthcare services comprising 190 hospitals and approximately 2,400 ambulatory sites of care, including surgery centers, freestanding ERs, urgent care centers, and physician clinics, in 20 states and the United Kingdom.
All references to “Company” and “HCA” as used throughout this release refer to HCA Healthcare, Inc. and its affiliates.
| Last Trade: | US$314.79 |
| Daily Change: | 1.92 0.61 |
| Daily Volume: | 886,870 |
| Market Cap: | US$79.740B |
February 18, 2025 October 25, 2024 October 17, 2024 July 23, 2024 | |
ClearPoint Neuro is a global therapy-enabling platform company providing stereotactic navigation and delivery to the brain. Applications of our ClearPoint Neuro Navigation System include electrode lead placement, placement of catheters, and biopsy. The platform has FDA clearance and is...
CLICK TO LEARN MORE
Amneal Pharmaceuticals is a fully-integrated essential medicines company. We make healthy possible through the development, manufacturing, and distribution of generic and specialty pharmaceuticals. The Company has a diverse portfolio of over 250 products in its Generics segment and is expanding across...
CLICK TO LEARN MORE
